Axys Pharmaceuticals Names Paul J. Hastings President and Chief Executive Officer.
Business Wire › December 04, 2000
Linked as:
Extract
Axys Pharmaceuticals Names Paul J. Hastings President and Chief Executive Officer.
Business Editors and Health/Medical Writers
SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--Dec. 4, 2000 Axys Pharmaceuticals, Inc. (Nasdaq:AXPH), an integrated small molecule drug discovery and development company, today announced that Paul J. Hastings, 40, has been appointed president and chief executiv...See the full content of this document
Sponsored links
